Advanced Wound Care World Market 2014-2024

©noticeThis material is copyright by visiongain. It is against the law to reproduce any of this material without the prior written agreement of vision-gain. You cannot photocopy, fax, download to database or duplicate in any other way any of the material contained in this report. Each pur-chase and single copy is for personal use only.

Advanced Wound Care: World Market Forecast 2014-2024 & Future Prospects

for Leading Companies

www.visiongain.com

Contents

1.1 Market Highlights

1.2 Overview of the Report Content

1.3 Research and Analysis Methods

1.4 Glossary of Terms Related to Advanced Wound Care

2.1 Wound: A Concise Definition

2.2 Wounds: Healing-Based Classification

2.2.1 Acute Wounds

2.2.2 Chronic Wounds

2.2.2.1 The Rising Prevalence of Chronic Wounds

2.2.3 Burns

2.3 An introduction to the Skin

2.4 The Phases of Wound Healing

2.4.1 The inflammatory Phase of Wound Healing

2.4.2 The Proliferation Phase of Wound Healing

2.4.3 The Fibroblastic Phase of Wound Healing

2.4.4 The Maturation Phase of Wound Healing

2.5 Wound Care

2.5.1 The Role of Wound Dressing

2.5.2 Wound Care: A Journey through History

2.6 Classification of Wound Care Therapies

2.6.1 Traditional Wound Care

2.6.1.1 Composite Dressings

2.6.1.2 Absorptive Dressings

2.6.1.3 Gauze Dressings

2.6.1.4 Contact Layers

1. Executive Summary

2. An Introduction to Wounds and Wound Care

www.visiongain.com

Contents

2.6.1.5 Compression Therapy

2.6.2 Advanced Wound Care

2.6.2.1 Moist Wound Care

2.6.2.1.1 Hydrocolloid Dressings

2.6.2.1.2 Foam Dressings

2.6.2.1.3 Alginate Dressings

2.6.2.1.4 Hydrogel Dressings

2.6.2.2 Wound Care Devices

2.6.2.2.1 Ultrasound for Wound Therapy

2.6.2.2.2 Negative Pressure Wound Therapy (NPWT)

2.6.2.3 Wound Care Biologics

2.6.2.3.1 Cell Based Therapies

2.6.2.3.2 Skin Replacement Therapies

2.6.2.3.3 Collagen Based Therapies

2.7 Regulation of Medical Devices

2.7.1 The US Approval and Regulation System

2.7.2 The EU Approval and Regulation System

2.7.2.1 Post-marketing Surveillance in the EU

3.1 The Global Medical Device Market in 2012 and 2013

3.2 Wound Care: Global Market Overview, 2012 and 2013

3.2.1 Global Wound Care Market Trends

3.3 The Advanced Wound Care Market in 2012 and 2013

3.3.1 Advanced Wound Care: Market Forecast 2014-2024

3.4 Changing Market Shares by Sector, 2014-2024

3. The Global Advanced Wound Care Market 2014-2024

www.visiongain.com

Contents

4.1 Moist Wound Care: Global Market Overview, 2012 and 2013

4.1.1 Moist Wound Care: Market Forecast 2014-2024

4.2 Moist Wound Care Market Breakdown

4.2.1 Hydrocolloid Dressings: Analysis and Forecast, 2014-2024

4.2.2 Foam Dressings: Analysis and Forecast, 2014-2024

4.2.3 Alginate Dressings: Analysis and Forecast, 2014-2024

4.2.4 Hydrogel Dressings: Analysis and Forecast, 2014-2024

4.2.5 Other Moist Wound Care Products: Analysis and Forecast, 2014-2024

4.3 Moist Wound Care: Pipeline Products, 2014

4.3.1 NanoDOX: A Topical Gel

4.3.2. ‘1’ Primary Wound Dressing: A Cell-Proliferating Spray

4.4 SWOT Analysis of the Moist Wound Care Market, 2014-2024

4.4.1 Strengths

4.4.1.1 Greater Effectiveness Compared with Traditional Wound Care

4.4.1.2 Large Range of Available Products

4.4.2 Weaknesses

4.4.2.1 A Diminishing R&D Pipeline

4.4.2.2 Questionable Effectiveness in Comparison to Some Devices and Biologics

4.4.3 Opportunities

4.4.3.1 More Affordable Compared to Wound Care Devices and Biologics

4.4.3.2 Increasing Prevalence of Chronic Wounds

4.4.4 Threats

4.4.4.1 The Threat of Emerging Technologies

4.4.4.2 Decreasing R&D Funding will Impact on Innovation

5.1 Wound Care Devices: Global Market Overview, 2012 and 2013

4. Moist Wound Care Market 2014-2024

5. Wound Care Devices Market 2014-2024

www.visiongain.com

Contents

5.1.1 Wound Care Devices Market Forecast 2014-2024

5.2 Wound Care Devices Market Breakdown

5.2.1 NPWT: Largest Segment of the Wound Care Devices Market

5.2.1.1 NPWT Market: Leading Products

5.2.1.2 V.A.C. Therapy

5.2.1.3 RENASYS Systems

5.2.1.4 Other NPWT Systems

5.2.1.5 NPWT Market: Analysis and Forecast, 2014-2024

5.2.2 Ultrasound Wound Therapy

5.2.2.1 Ultrasound Wound Therapy: Leading Products

5.2.2.2 Ultrasound Wound Therapy Market: Analysis and Forecast, 2014-2024

5.2.3 Other Wound Care Devices

5.2.3.1 Electrical Stimulation

5.3 Wound Care Devices: Pipeline Products, 2014

5.3.1 dermaPACE, Sanuwave Health

5.3.2 O-ACE-Sys, Ingenious Technologies Corporation

5.3.3 Red Light Wave Therapy, Lightwave Technologies

5.4 SWOT Analysis of the Wound Care Devices Market, 2014-2024

5.4.1 Strengths

5.4.1.1 Continuous Innovation and a Strong R&D pipeline

5.4.1.2 Higher Effectiveness Compared with Other Treatments

5.4.2 Weaknesses

5.4.2.1 The Dominance of Negative Pressure Wound Therapy

5.4.2.2 An Oligopolistic Market

5.4.3 Opportunities

5.4.3.1 Decreasing Prices will Drive Market Growth

5.4.3.2 Increasing Prevalence of Chronic Wounds

5.4.4 Threats

5.4.4.1 Litigation: A Threat to Innovation

www.visiongain.com

Contents

6.1 Wound Care Biologics: Global Market Overview, 2012 and 2013

6.1.1 Wound Care Biologics Market Forecast 2014-2024

6.2 Wound Care Biologics Market Breakdown

6.2.1 Skin Replacement Therapies: High Growth Potential

6.2.1.1 Skin Replacement Therapies Market: Leading Products

6.2.1.1.1 Apligraf, Organogenesis

6.2.1.1.2 Dermagraft, Organogenesis (Formerly of Shire Regenerative

Medicine)

6.2.1.1.3 Other Skin Replacement Therapies

6.2.1.2 Skin Replacement Therapies Market: Pipeline Products, 2014

6.2.1.3 Skin Replacement Therapies: Analysis and Forecast, 2014-2024

6.2.2 Collagen Based Therapies

6.2.2.1 Collagen Based Therapies: Leading Products

6.2.2.2 Collagen Based Therapies: Analysis and Forecast, 2014-2024

6.2.3 Cell Therapies

6.2.3.1 Cell Therapies Market: Leading Products

6.2.3.2 Cell Therapies: Analysis and Forecast, 2014-2024

6.2.4 Other Wound Care Biologics

6.3 Wound Care Biologics: Pipeline Products, 2014

6.3.1 Stem Cells

6.3.1.1 Stem Cell Skin Gun, Mc Gowan Institute for Regenerative Medicine:

University of Pittsburgh

6.3.1.2 Mesenchymal Stem Cells: Nara University, Japan

6.3.2 Nanotechnology

6.3.2.1 Phytochemical Tissue Bonding: Harvard University Institute of

Photomedicine

6.3.2.2 DermaFuse: Missouri S&T and Mo-Sci Corporation

6.3.3 Artificial Skin

6. Wound Care Biologics Market 2014-2024

www.visiongain.com

Contents

6.3.3.1 ReCell: Avita Medical

6.3.3.2 e-Skin: UC Berkeley

6.3.3.3 Automated Artificial Skin Production: Fraunhofer Institute

6.3.4 Collagen Based Wound Therapy: Cornell University

6.4 SWOT Analysis of the Wound Care Biologics Market, 2014-2024

6.4.1 Strengths

6.4.1.1 Fresh Innovations Producing New Technologies

6.4.1.2 Greater Effectiveness of Biologics

6.4.1.3 Rich R&D Pipeline: A Driver for Market Growth

6.4.2 Weaknesses

6.4.2.1 Barriers to Entry: High

6.4.2.2 The Dominance of Small Biotech Companies

6.4.2.3 The Price of Biologics: A Potential Restraint to Reimbursement

6.4.3 Opportunities

6.4.3.1 The Prospect of Diagnostic Testing

6.4.3.2 Rising Prevalence of Chronic Wounds

6.4.3.3 Stem Cells: Possibility for the Treatment of Multiple Indications

6.4.4 Threats

6.4.4.1 The Competition from Moist Wound Care and Devices

6.4.4.2 High Barrier to Entry: A Strong Deterrent

7.1 The Advanced Wound Care Market by Regional Sales

7.1.1 The Global Distribution of Advanced Wound Care in 2012 and 2013

7.2 Leading National Markets: Forecast, 2014-2024

7.2.1 Changing Market Shares by Region, 2014-2024

7.3 Regional Advanced Wound Care Markets: Analysis and Forecasts, 2014-2024

7.3.1 United States: A Tale of Taxes and Changing Reimbursement Models

7.3.2 The EU5 Markets: Europe’s Leading AWC Markets

7. Leading National Advanced Wound Care Markets 2014-2024

www.visiongain.com

Contents

7.3.2.1 EU5: Changing Market Shares by Country, 2014-2024

7.3.2.2 Germany: Europe’s Largest Advanced Wound Care Market

7.3.2.3 France: Cumbersome Approval Process Slowing Growth

7.3.2.4 UK: Hospital Inpatients Raising Wound Care Needs

7.3.2.5 Spain: Rationalisation of Healthcare Expenditure Impacting Sales

7.3.2.6 Italy: Gloom Outlook Compounded by Dropping Credit Ratings

7.3.3 Japan: An Aging Population Putting a Strain on Healthcare Budgets

7.3.4 The BRIC Nations

7.3.4.1 China: High Unmet Needs and Expanding Healthcare Coverage will Drive

Growth

7.3.4.2 India: High Domestic Growth and a Rapidly Expanding Economy

7.3.4.3 Russia: Irregularities in Legislations Hindering Growth

7.3.4.4 Brazil: Expanding Waistlines and Diabetic Population

7.3.5 South Korea: A Highly Attractive Market to Multinationals

8.1 Kinetic Concept Inc: Global Market Leader

8.1.1 NPWT: A Major Market for KCI

8.1.2 VAC Therapy (NPWT): A Success Story

8.1.3 Systagenix and Kinetic Concept Merger

8.2 Smith & Nephew

8.2.1 S&N’s Advanced Wound Management

8.3 Molnlycke Healthcare

8.3.1 Molnlycke’s Advanced Wound Care Product Range

8.3.2 Molnlycke: Revenue Analysis, 2012 and 2013

8.4 ConvaTec

8.4.1 ConvaTec Revenue Analysis, 2012 and 2013

8.4.2 Wound Therapeutics: A Golden Goose for ConvaTec

8.5 3M

8. Leading Companies in the Advanced Wound Care Market 2014

www.visiongain.com

Contents

8.5.1 3M: Skin & Wound Care

8.5.2 3M Healthcare Revenue Analysis, 2012 and 2013

8.6 Coloplast

8.6.1 Coloplast’s European Orientation

9.1 Interview with Mr. Nissim Mashiach, President and Chief Executive Officer, MacroCure

9.1.1 On the Current State of the Advanced Wound Care Market

9.1.2 On the Fate of the Moist Wound Care Sector

9.1.3 MacroCure’s Place in the Advanced Wound Care Market

9.1.4 On the Company’s Growth Strategy and European Expansion

9.1.5 The Multi-Faceted Nature of Wound Care and Wound Healing

9.1.6 On the Challenges Facing the Advanced Wound Care Market

9.1.7 Possible Use of Advanced Wound Care Therapies for Other Indications

9.1.8 Views on the Future Prospects of the Market

10.1 Market Overview

10.2 Wound Care Devices and Biologics Set for Rapid Sales Boost

10.3 Rising Prevalence of Chronic Wounds: A Driver for Growth

10.4 Emerging Markets will help in Driving Growth

10.5 Moist Wound Care: Market Summary

10.6 Wound Care Devices: Market Summary

10.7 Wound Care Biologics: Market Summary

9. Expert Opinions

10. Conclusions

www.visiongain.com

Contents

Table 2.1 Burn Assessment: The ‘Rule of Nine’ Total Body Classification System (%)

Table 2.2 The Classification of Burns by Depth: Degree Classification System

Table 2.3 The Classification of Burns by Severity

Table 2.4 Advanced Wound Care: Sectors and Descriptions, 2014

Table 2.5 Advantages and Disadvantages of Moist Wound Care

Table 2.6 Advantages and Disadvantages of Skin Replacement Therapy

Table 2.7 Skin Graft Types and their Descriptions

Table 3.1 The Medical Devices Market: Revenues ($bn) and Market Shares (%) by Sector, 2012

Table 3.2 Global Wound Care Market: Revenue ($bn) and Market Share (%) by Sector, 2012

Table 3.3 The Advanced Wound Care Market: Revenues ($bn), Market Shares (%) and Growth

(%) by Sector, 2012 and 2013

Table 3.4 The Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%) by

Sector, 2012-2024

Table 3.5 Advanced Wound Care Market Forecast: CAGR (%) by Sector, 2013-2018, 2018-2024,

and 2013-2024

Table 3.6 The Advanced Wound Care Market: Revenue ($bn) by Sector, 2012, 2018, 2024

Table 3.7 The Advanced Wound Care Market: Market Share (%) by Sector, 2012, 2018, 2024

Table 3.8 The Advanced Wound Care Market: Drivers and Restraints, 2014-2024

Table 4.1 Moist Wound Care Market: Revenues ($bn), Market Shares (%) and Growth (%) by

Sector, 2012 and 2013

Table 4.2 The Moist Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%) by Sector,

2012-2024

Table 4.3 Hydrocolloid Dressings Market: Revenue Forecast ($bn, AGR%, CAGR%), 2012-2024

Table 4.4 Foam Dressings Market: Revenue Forecast ($bn, AGR%, CAGR%), 2012-2024

Table 4.5 Alginate Dressings Market: Revenue Forecast ($bn, AGR%, CAGR%), 2012-2024

Table 4.6 Hydrogel Dressings Market: Revenue Forecast ($bn, AGR%, CAGR%), 2012-2024

Table 4.7 Selected Moist Wound Care Products, 2014

Table 4.8 Moist Wound Care Pipeline Products, 2014

List of Tables

www.visiongain.com

Contents

Table 4.9 SWOT Analysis of the Moist Wound Care Market, 2014-2024

Table 5.1 Wound Care Devices Market: Revenues ($bn), Market Shares (%) and Growth (%) by


Table 5.2 The Wound Care Devices Market: Revenue Forecast ($bn, AGR%, CAGR%) by Sector,

2012-2024

Table 5.3 The Negative Pressure Wound Therapy (NPWT) Market: Revenue Forecast ($bn,

AGR%, CAGR%), 2012-2024

Table 5.4 The Negative Pressure Wound Therapy (NPWT) Market: Drivers and Restraints, 2014-

2024

Table 5.5 Ultrasound Wound Therapy: Leading Products, 2014

Table 5.6 The Ultrasound Wound Therapy Market: Revenue Forecast ($bn, AGR%, CAGR%),

2012- 2024

Table 5.7 Electrical Stimulation Devices: Leading Products, 2014

Table 5.8 Wound Care Devices Pipeline Products, 2014

Table 5.9 SWOT Analysis of the Wound Care Devices Market, 2014-2024

Table 6.1 Wound Care Biologics Market: Revenues ($bn), Market Shares (%) and Growth (%) by


Table 6.2 The Wound Care Biologics Market: Revenue Forecast ($m, AGR%, CAGR%) by Sector,

2012-2024

Table 6.3 Wound Care Biologics: Market Drivers and Restraints, 2014-2024

Table 6.4 Skin Replacement Therapies: Leading Products, 2014

Table 6.5 The Skin Replacement Therapies Market: Revenue Forecast ($m, AGR%, CAGR%),

2012- 2024

Table 6.6 Collagen Based Therapies: Leading Products, 2014

Table 6.7 The Collagen Based Therapies Market: Revenue Forecast ($m, AGR%, CAGR%), 2012-

2024

Table 6.8 Cell Therapies: Leading Products, 2014

Table 6.9 The Cell Therapies Market: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024

Table 6.10 Other Wound Care Biologics Therapies, 2014

Table 6.11 Wound Care Biologics Pipeline Products, 2014

Table 6.12 SWOT Analysis of the Wound Care Devices Market, 2014-2024

www.visiongain.com

Contents

Table 7.1 The Advanced Wound Care Market: Revenues ($bn) and Growth (%) by Region, 2012

and 2013

Table 7.2 The Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%) by

Region, 2012-2024

Table 7.3 Advanced Wound Care Market Forecast: CAGR (%) by Region, 2013-2018, 2018-

2024, and 2012-2024

Table 7.4 The Advanced Wound Care Market: Market Shares (%) by Region, 2012, 2018, 2024

Table 7.5 The US Advanced Wound Care Market Forecast: Market Size ($bn), Rank, Market

Share (%) and CAGR (%), 2012-2024

Table 7.6 US Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%), 2012-

2024

Table 7.7 The EU5 Advanced Wound Care Market Forecast: Market Size ($bn), Market Share

(%) and CAGR (%), 2012-2024

Table 7.8 The EU5 Advanced Wound Care Market: Revenues ($bn) and Growth (%) by Region,

2012 and 2013

Table 7.9 The EU5 Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%) by

Country, 2012-2024

Table 7.10 The EU5 Advanced Wound Care Market: Market Shares (%) by Country, 2012, 2018,

2024

Table 7.11 The German Advanced Wound Care Market Forecast: Market Size ($bn), Rank,

Market Share (%) and CAGR (%), 2012-2024

Table 7.12 The German Advanced Wound Care Market: Revenue Forecast ($bn, AGR%,

CAGR%), 2012-2024

Table 7.13 The French Advanced Wound Care Market Forecast: Market Size ($bn), Rank, Market

Share (%) and CAGR (%), 2012-2024

Table 7.14 The French Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%),

2012-2024

Table 7.15 The UK Advanced Wound Care Market Forecast: Market Size ($bn), Rank, Market

Share (%) and CAGR (%), 2012-2024

Table 7.16 The UK Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%),

2012-2024

www.visiongain.com

Contents

Table 7.17 The Spanish Advanced Wound Care Market Forecast: Market Size ($bn), Rank,


Table 7.18 The Spanish Advanced Wound Care Market: Revenue Forecast ($bn, AGR%,

CAGR%), 2012-2024

Table 7.19 The Italian Advanced Wound Care Market Forecast: Market Size ($bn), Rank, Market

Share (%) and CAGR (%), 2012-2024

Table 7.20 The Italian Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%),

2012-2024

Table 7.21 The Japanese Advanced Wound Care Market Forecast: Market Size ($bn), Rank,


Table 7.22 The Japanese Advanced Wound Care Market: Revenue Forecast ($bn, AGR%,

CAGR%), 2012-2024

Table 7.23 The Chinese Advanced Wound Care Market Forecast: Market Size ($bn), Rank,


Table 7.24 The Chinese Advanced Wound Care Market: Revenue Forecast ($bn, AGR%,

CAGR%), 2012-2024

Table 7.25 The Indian Advanced Wound Care Market Forecast: Market Size ($bn), Rank, Market

Share (%) and CAGR (%), 2012-2024

Table 7.26 The Indian Advanced Wound Care Market: Revenue Forecast ($bn, AGR%, CAGR%),

2012-2024

Table 7.27 The Russian Advanced Wound Care Market Forecast: Market Size ($bn), Rank,


Table 7.28 The Russian Advanced Wound Care Market: Revenue Forecast ($bn, AGR%,

CAGR%), 2012-2024

Table 7.29 The Brazilian Advanced Wound Care Market Forecast: Market Size ($bn), Rank,


Table 7.30 The Brazilian Advanced Wound Care Market: Revenue Forecast ($bn, AGR%,

CAGR%), 2012-2024

Table 7.31 The South Korean Advanced Wound Care Market Forecast: Market Size ($bn), Rank,


Table 7.32 The South Korean Advanced Wound Care Market: Revenue Forecast ($bn, AGR%,

www.visiongain.com

Contents

CAGR%), 2012-2024

Table 8.1 KCI’s VAC Therapies at a Glance, 2014

Table 8.2 Smith & Nephew: Historical Revenue ($bn, AGR %), 2008-2012

Table 8.3 Smith & Nephew: Revenue by Segment ($bn), 2012

Table 8.4 Smith & Nephew Advanced Wound Management: Revenue ($bn) and Revenue Share

(%) by Segment, 2012

Table 8.5 Smith & Nephew Advanced Wound Management: Revenue ($bn) and Revenue Share

(%) by Region, 2012

Table 8.6 Molnlycke Advanced Wound Care Products and Description, 2014

Table 8.7 Molnlycke: Historical Revenue ($bn, AGR %), 2008-2012

Table 8.8 ConvaTec’s Wound Therapeutics Products and Description, 2014

Table 8.9 ConvaTec: Revenue ($m) and Revenue Share (%) by Segment, 2012

Table 8.10 ConvaTec: Historical Wound Therapeutics Revenue ($m, AGR %), 2009-2012

Table 8.11 3M: Revenue ($m) and Revenue Shares (%) by Franchise, 2012

Table 8.12 3M: Tegaderm Wound Care Products and Description, 2014

Table 8.13 3M: Historical Healthcare Revenue ($bn, AGR %), 2008-2012

Table 8.14 Coloplast: Revenue ($m) and Revenue Share (%) by Segment, 2013

Table 8.15 Coloplast: Revenue ($m) and Revenue Growth (%) by Region, 2012, 2013

Table 10.1 Projected Advanced Wound Care Market Size ($bn, CAGR%): 2012, 2017, 2020,

2024

Table 10.2 The Global Advanced Wound Care Market: Revenue ($bn) by Sector, 2012, 2017,

2020, 2024

Table 10.3 The Global Advanced Wound Care Market: Market Share (%) by Sector, 2012, 2017,

2020, 2024

Figure 2.1 Wound Healing Phases and Duration (Days)

Figure 2.2 Functions of Wound Dressing

Figure 3.1 The Medical Device Market: Revenue (£bn) by Sector, 2012

List of Figures

www.visiongain.com

Contents

Figure 3.2 The Medical Device Market: Market Shares (%) by Sector, 2012

Figure 3.3 Global Wound Care Market: Revenue ($bn) by Sector, 2012

Figure 3.4 Global Wound Care Market: Market Share (%) by Sector, 2012

Figure 3.5 The Advanced Wound Care Market: Revenues ($bn) by Sector, 2012 and 2013

Figure 3.6 The Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024

Figure 3.7 Advanced Wound Care Market Forecast: CAGR (%) by Sector, 2013-2018

Figure 3.8 Advanced Wound Care Market Forecast: CAGR (%) by Sector, 2018-2024

Figure 3.9 Advanced Wound Care Market Forecast: CAGR (%) by Sector, 2013--2024

Figure 3.10 The Advanced Wound Care Market: Revenue ($bn) by Sector, 2012, 2018, 2024

Figure 3.11 The Advanced Wound Care Market: Market Share (%) by Sector, 2012



Figure 4.1 Moist Wound Care Market: Revenue ($bn) by Sector, 2012

Figure 4.2 Moist Wound Care Market: Market Share (%) by Sector, 2012

Figure 4.3 The Moist Wound Care Market: Revenue Forecast ($bn), 2012-2024

Figure 4.4 Hydrocolloid Dressings Market: Revenue Forecast ($bn), 2012-2024

Figure 4.5 Foam Dressings Market: Revenue Forecast ($bn), 2012-2024

Figure 4.6 Alginate Dressings Market: Revenue Forecast ($bn), 2012-2024

Figure 4.7 Hydrogel Dressings Market: Revenue Forecast ($bn), 2012-2024

Figure 5.1 Wound Care Devices Market: Revenue ($bn) by Sector, 2012, 2013

Figure 5.2 Wound Care Devices Market: Market Share (%) by Sector, 2012

Figure 5.3 The Wound Care Devices Market: Revenue Forecast ($bn), 2013-2024

Figure 5.4 The Negative Pressure Wound Therapy (NPWT) Market: Revenue Forecast ($bn),

2012-2024

Figure 5.5 The Ultrasound Wound Therapy Market: Revenue Forecast ($bn), 2012-2024

Figure 6.1 Wound Care Biologics Market: Revenue ($bn) by Sector, 2012, 2013

Figure 6.2 Wound Care biologics Market: Market Share (%) by Sector, 2012

Figure 6.3 The Wound Care Biologics Market: Revenue Forecast ($m), 2012-2024

Figure 6.4 The Skin Replacement Therapies Market: Revenue Forecast ($m), 2012-2024

Figure 6.5 The Collagen Based Therapies Market: Revenue Forecast ($m), 2012-2024

Figure 6.6 The Cell Therapies Market: Revenue Forecast ($m), 2012-2024

www.visiongain.com

Contents

Figure 7.1 The Advanced Wound Care Market: Revenues ($bn) by Region, 2012

Figure 7.2 US, EU5, Japan, and China Advanced Wound Care Market: Revenue Forecast ($bn),

2012-2024

Figure 7.3 Russia, Brazil, and South Korea Advanced Wound Care Market: Revenue Forecast

($bn), 2012-2024

Figure 7.4 Advanced Wound Care Market Forecast: CAGR (%) by Region, 2013-2018



Figure 7.7 The Advanced Wound Care Market: Market Shares (%) by Region, 2012



Figure 7.10 US Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024

Figure 7.11 The EU5 Advanced Wound Care Market: Revenues ($bn) by Region, 2012

Figure 7.12 Germany, France, UK, Spain, and Italy Advanced Wound Care Market: Revenue

Forecast ($bn), 2012-2024

Figure 7.13 The EU5 Advanced Wound Care Market: Market Shares (%) by Country, 2012

Figure 7.14 The Advanced Wound Care Market: Market Shares (%) by Country, 2024

Figure 7.15 The German Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024

Figure 7.16 The French Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024

Figure 7.17 The UK Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024

Figure 7.18 The Spanish Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024

Figure 7.19 The Italian Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024

Figure 7.20 The Japanese Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024

Figure 7.21 The Chinese Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024

Figure 7.22 The Indian Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024

Figure 7.23 The Russian Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024

Figure 7.24 The Brazilian Advanced Wound Care Market: Revenue Forecast ($bn), 2012-2024

Figure 7.25 The South Korean Advanced Wound Care Market: Revenue Forecast ($bn), 2012-

2024

Figure 8.1 Kinetic Concept Inc: Strengths and Threats, 2014-2024

Figure 8.2 Smith & Nephew: Historical Revenue ($bn), 2008-2012

www.visiongain.com

Contents

Figure 8.3 Smith & Nephew: Revenue by Segment ($bn), 2012

Figure 8.4 Smith & Nephew: Revenue by Segment (%), 2012

Figure 8.5 Smith & Nephew Advanced Wound Management: Revenue ($bn) by Franchise, 2012

Figure 8.6 Smith & Nephew Advanced Wound Management: Revenue Share (%) by Franchise,

2012

Figure 8.7 Smith & Nephew Advanced Wound Management: Revenue ($bn) by Region, 2012

Figure 8.8 Smith & Nephew Advanced Wound Management: Revenue Share (%) by Region,

2012

Figure 8.9 Molnlycke: Strengths and Threats, 2014-2024

Figure 8.10 Molnlycke: Historical Revenue ($bn), 2008-2012

Figure 8.11 ConvaTec: Revenue ($m) by Segment,, 2012

Figure 8.12 ConvaTec: Revenue Share (%) by Segment,, 2012

Figure 8.13 ConvaTec: Historical Wound Therapeutics Revenue ($m), 2009-2012

Figure 8.14 3M: Revenue Shares (%) by Franchise, 2012

Figure 8.15 3M: Historical Healthcare Revenue ($bn), 2008-2012

Figure 8.16 Coloplast: Revenue ($m) by Segment, 2013

Figure 8.17 Coloplast: Revenue Share (%) by Segment, 2013

Figure 8.18 Coloplast: Revenue ($m) by Region, 2012, 2013

Figure 8.19 Coloplast: Revenue Share (%) by Region, 2013

Figure 10.1 Projected Advanced Wound Care Market Size ($bn): 2012, 2017, 2020, 2024

Figure 10.2 The Global Advanced Wound Care Market: Revenue ($bn) by Sector, 2012, 2017,

2020, 2024

Figure 10.3 Global Over-60 Population: Historical Proportions and Forecast (%), 1950, 2009,

2050

Figure 10.4 The Global Advanced Wound Care Market: Market Share (%) by Sector, 2012, 2017,

2020, 2024

www.visiongain.com

Contents

3M

Advanced BioHealing (Shire)

Advanced Tissue Sciences

Anika Therapeutics

Avista Capital Partners

Avita Medical

Biolight AB

BlueSky Medical (S&N)

Boehringer Ingelheim

Brennen Medical

Bristol-Myers Squibb

BSN Medical Gmbh

Celleration

Coloplast

ConvaTec

Covalon Technologies

Covidien

Derma Sciences

Devon Medical Products

Dow-Hickman

Dr Suwelack Skin & Health Care

Garnet Biotherapeutics

Genzyme Biosurgery

Gerromed GmbH

Getinge

Forticell Bioscience (formerly Ortec International)

Hartmann Group

Healo Medical

Companies Mentioned in this Report

www.visiongain.com

Contents

Healthpoint Biotherapeutics

Hollister Wound Care

Human Biosciences

Ingenious Technologies Corporation

Innocoll

Innovative Therapies

Integra Life Science Corp

Investor AB

IYIA Technologies

Johnson & Johnson

Kaken Pharmaceuticals

Kalypto Medical

Kinetic Concepts

Laboratoires URGO

Lescarden

Lifecell

Lightwave Technologies

MacroCure

Marine Polymer Technologies Inc

Medela

Medestea Internazionale

Medline Industries

MiMedX

MiMedX

Misonix

Molnlycke

Mo-Sci Corporation

Nanotherapeutics

Nordic Capital Partners

Organogenesis

Osiris Therapeutics

www.visiongain.com

Contents

Politec Saude

Polyheal

Promethean LifeSciences

Prospera

Phytoceuticals

RedDress

Sangui BioTech International

Sanuwave Health

Shire Regenerative Medicine

Smith & Nephew

Soring

Synapse Microcurrent

Systagenix (now part of KCI)

Talley Group

Vario

Vomaris Innovations

Wake Forest University

Wound Management Technologies

Wright Medical

www.visiongain.com

Contents

Armed Forces Institute of Regenerative Medicine (AFIRM)

Center for Disease Control

Centers for Medicare and Medicaid Services (CMS)

Central Drug Standard Control Organisation (CDSCO) [India]

Centre for Devices and Radiological Health (CDRH)

Cornell University

European Databank on Medical Devices (EUDAMED)

Food and Drug Administration (FDA)

Fraunhofer Institute

Health Insurance Bureau [Japan]

Institute of Photomedicine, Harvard University

International Diabetic Federation (IDF)

International Medical Device Regulators Forum (IMDRF) (formerly GHTF)

Italian National Health Service

Masachussetts General Hospital (MGH)

McGowan Institute for Regenerative Medicine, University of Pittsburgh

Ministry of Health & Family Welfare [India]

Ministry of Health, Labour and Welfare (MHLW)

Ministry of Health, Labour, and Welfare (MHLW) [Japan]

Missouri University of Science and Technology

Moody’s Investor service

Nara University, Japan

National Competent Authorities (NCAs)

National Health Service (NHS)

North Florida/ South Georgia Veterans Health System

Pharmaceuticals and Medical Devices Agency (PMDA) [Japan]

Roszdravnadzor [Russia]

Standard and Poors Rating Services

Organisations Mentioned in this Report

www.visiongain.com

Contents

The World Bank

University of California, Berkeley

United Nations (UN)

University Hospital Bern

Wellman Centre for Photomedicine, Harvard University

www.visiongain.com

Advanced Wound Care: Market Forecast 2014-2024 & Future Prospects for Leading Companies

Table 4.3 Hydrocolloid Dressings Market: Revenue Forecast ($bn, AGR%, CAGR%),

2012-2024

2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024Hydrocolloid Dressing ($bn) 1.2 1.3 1.3 1.3 1.4 1.4 1.5 1.6 1.6 1.6 1.6 1.7 1.7

AGR (%) 2 3 3 3 4 4 4 1 2 2 1 1CAGR (%) 2013-18

CAGR (%) 2013-24

3.4 2018-24 1.8

2.5

Visiongain forecasts the revenue from hydrocolloid dressings to reach $1.5bn in 2018 (Figure 4.4),

growing at a CAGR of 3.4% from 2013. The hydrocolloid dressing market will be driven by

increased prevalence of chronic and acute wounds. This market is dominated by multinational

companies such as 3M, ConvaTec, Smith &Nephew, and Coloplast who have been in the market

for a long while. Controversy regarding the use of hydrocolloid dressings in the treatment of

diabetic ulcers may restrain growth in the market during the forecast period. Visiongain predicts

slow growth in the hydrocolloid dressing market from 2014 to 2024 with the market growing to

$1.7bn in 2024, at a CAGR of 1.8% from 2018 to 2024.

4.2.2 Foam Dressings: Analysis and Forecast, 2014-2024 Foam dressings accounted for 26.5% of the moist wound care market with $1.0bn in global sales.

Many foam dressings in the market have been combined with anti-bacterials such as silver to

reduce infection and to heal wounds faster. As more innovative combinations reach the market, the

benefits of foam dressings will be seen. ALLEVYN (Smith & Nephew), Lyofoam (Molnlycke) and

3M Tegaderm Foam (3M) are some of the leading foam dressings in the market. The versatility

and affordability of foam dressings makes them an attractive choice among moist wound care

products. Emerging economies will drive growth in the moist wound care market, and visiongain

predicts that foam dressings will benefit the most. The foam dressing market will increase to

$1.4bn in 2018, with a CAGR of 6.0% between 2013 and 2018. The market will then increase to

$1.7bn in 2024, growing at a CAGR of 3.5% between 2018 and 2024 (Table 4.4 and Figure 4.5).

Source: Visiongain 2014

www.visiongain.com


Table 7.32 The South Korean Advanced Wound Care Market: Revenue Forecast ($bn,

AGR%, CAGR%), 2012-2024

2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024South Korean Market ($bn) 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3 0.4

AGR (%) 12 12 12 14 14 15 13 13 11 10 9 8CAGR (%) 2013-18

CAGR (%) 2013-24 11.8

13.4 2018-24 10.4

Figure 7.25 The South Korean Advanced Wound Care Market: Revenue Forecast ($bn),

2012-2024

0.1 0.1 0.1

0.2 0.2

0.2 0.2

0.3 0.3

0.3 0.3

0.4

0.0

0.1

0.2

0.3

0.4

2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Rev

enue

($bn

)

Year



www.visiongain.com


Figure 8.1 Kinetic Concept Inc: Strengths and Threats, 2014-2024

Systagenix is based in the UK, and in collaboration with Alere developed WOUNDCHEK Protease

status, the world’s first point of care diagnostic test for chronic wounds. The product was launched

in January 2012 across Europe, South Africa and the Middle East. Although it has been widely

understood that Elevated Protease Activity (EPA) is the key marker in wound healing, it used to be

undetected in the past. The Wound Check protease for EPA measurement provides results in 15

minutes enabling the clinician to decide the best treatment for each patient. The product has not

yet been approved by the US FDA.

KCI decided to expand its operations to Brazil in 2012, following the previous year’s launch of its

NPWT systems in the Japanese, Chinese and Indian markets. This will help the company to boost

its revenue during the forecast period. The merger between KCI and Systagenix will help to

diversify the group’s product portfolio, which will act as a catalyst to stimulate revenue growth for

the group (Figure 8.1).

World leader in NPWT market offering a

wide range of products based on its

proprietary V.A.C therapy technology. KCI is

the trusted brand around the world for

NPWT products

KCI is strong in the biologics segment since

the acquisition of LifeCell Technologies in

2008. KCI is also constantly growing through

expansion into under penetrated markets.

The acquisition of Systagenix will help

consolidate its possible as market leader in

the AWC market

Strengths Threats

KCI will likely face strong competition to

maintain its market position in the NPWT

market.

It will have to compete with other established

providers of NPWT products as well as

newer companies introducing several NPWT

devices on the market.


Advanced Wound Care World Market 2014-2024

Business

Transcript of Advanced Wound Care World Market 2014-2024